Community/Retail

Officials with the FDA have approved cannabidiol oral solution (Epidiolex) for the treatment of seizures associated with 2 rare and severe forms of epilepsy, Lennox-Gastaut syndrome, and Dravet syndrome, in patients aged 2 years and older. This is the first FDA-approved drug that contains a purified drug substance derived from marijuana, and is the first FDA approval of a drug for the treatment of patients with Dravet syndrome.

In this clip, Arsany Makkar, a PharmD candidate at the Rutgers University Ernest Mario School of Pharmacy, shares his thoughts on the evolving role of pharmacists.